171 related articles for article (PubMed ID: 22822410)
1. Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.
Huang A; Hogan JW; Istrail S; Delong A; Katzenstein DA; Kantor R
Future Virol; 2012 May; 7(5):505-517. PubMed ID: 22822410
[TBL] [Abstract][Full Text] [Related]
2. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
J Virol; 1997 Sep; 71(9):6348-58. PubMed ID: 9261352
[TBL] [Abstract][Full Text] [Related]
3. Comparative HIV-1 Phylogenies Characterized by
Topcu C; Georgiou V; Rodosthenous JH; Kostrikis LG
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298841
[TBL] [Abstract][Full Text] [Related]
4. Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
Shafer RW; Eisen JA; Merigan TC; Katzenstein DA
J Virol; 1997 Jul; 71(7):5441-8. PubMed ID: 9188616
[TBL] [Abstract][Full Text] [Related]
5. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.
Gao F; Robertson DL; Morrison SG; Hui H; Craig S; Decker J; Fultz PN; Girard M; Shaw GM; Hahn BH; Sharp PM
J Virol; 1996 Oct; 70(10):7013-29. PubMed ID: 8794346
[TBL] [Abstract][Full Text] [Related]
6. Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools.
Pineda-Peña AC; Faria NR; Imbrechts S; Libin P; Abecasis AB; Deforche K; Gómez-López A; Camacho RJ; de Oliveira T; Vandamme AM
Infect Genet Evol; 2013 Oct; 19():337-48. PubMed ID: 23660484
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania.
Nyombi BM; Holm-Hansen C; Kristiansen KI; Bjune G; Müller F
AIDS Res Ther; 2008 Jun; 5():13. PubMed ID: 18570675
[TBL] [Abstract][Full Text] [Related]
8. Genetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins.
Troyano-Hernáez P; Reinosa R; Holguín A
Front Microbiol; 2022; 13():866705. PubMed ID: 35910645
[TBL] [Abstract][Full Text] [Related]
9. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
[TBL] [Abstract][Full Text] [Related]
10. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response.
Ojesina AI; Sankalé JL; Odaibo G; Langevin S; Meloni ST; Sarr AD; Olaleye D; Kanki PJ
AIDS Res Hum Retroviruses; 2006 Aug; 22(8):770-9. PubMed ID: 16910833
[TBL] [Abstract][Full Text] [Related]
11. Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades.
Bachmann MH; Mathiason-Dubard C; Learn GH; Rodrigo AG; Sodora DL; Mazzetti P; Hoover EA; Mullins JI
J Virol; 1997 Jun; 71(6):4241-53. PubMed ID: 9151811
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.
Apetrei C; Descamps D; Collin G; Loussert-Ajaka I; Damond F; Duca M; Simon F; Brun-Vézinet F
J Virol; 1998 May; 72(5):3534-8. PubMed ID: 9557632
[TBL] [Abstract][Full Text] [Related]
13. Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults.
Becker-Pergola G; Kataaha P; Johnston-Dow L; Fung S; Jackson JB; Eshleman SH
AIDS Res Hum Retroviruses; 2000 May; 16(8):807-13. PubMed ID: 10826487
[TBL] [Abstract][Full Text] [Related]
14. New subtypes and genetic recombination in HIV type 1-infecting patients with highly active antiretroviral therapy in Peru (2008-2010).
Yabar CA; Acuña M; Gazzo C; Salinas G; Cárdenas F; Valverde A; Romero S
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1712-22. PubMed ID: 22559065
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 subtyping using phylogenetic analysis of pol gene sequences.
Pasquier C; Millot N; Njouom R; Sandres K; Cazabat M; Puel J; Izopet J
J Virol Methods; 2001 May; 94(1-2):45-54. PubMed ID: 11337039
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola.
Afonso JM; Bello G; Guimarães ML; Sojka M; Morgado MG
PLoS One; 2012; 7(8):e42996. PubMed ID: 22952625
[TBL] [Abstract][Full Text] [Related]
18. The HIV-1 epidemic in Bolivia is dominated by subtype B and CRF12_BF "family" strains.
Guimarães ML; Velarde-Dunois KG; Segurondo D; Morgado MG
Virol J; 2012 Jan; 9():19. PubMed ID: 22248191
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
[TBL] [Abstract][Full Text] [Related]
20. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.
Carvalho BC; Cardoso LP; Damasceno S; Stefani MM
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1081-7. PubMed ID: 21417758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
